Previous studies have reported that PSME3 expression is increased in tumor tissues compared to normal tissues and that it acts as an oncogenic driver in many types of cancers (Chai et al., 2015; Li J. et al., 2015; Chen H. et al., 2017). Here, PSME3 is linked to neoplasm.